179 related articles for article (PubMed ID: 32957969)
1. Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends.
Sgalla G; Larici AR; Golfi N; Calvello M; Farchione A; Del Ciello A; Varone F; Iovene B; Manfredi R; Richeldi L
BMC Pulm Med; 2020 Sep; 20(1):249. PubMed ID: 32957969
[TBL] [Abstract][Full Text] [Related]
2. Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis.
Sin S; Lee KH; Hur JH; Lee SH; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
PLoS One; 2018; 13(7):e0201154. PubMed ID: 30044866
[TBL] [Abstract][Full Text] [Related]
3. Association between Parenchymal B-Cell Follicles and CT-Proven Enlarged Mediastinal Lymph Nodes in Patients with Pulmonary Fibrosis.
Kronborg-White S; Bendstrup E; Madsen LB; Rasmussen F; Poletti V
Respiration; 2023; 102(7):515-522. PubMed ID: 37290416
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease.
Grecuccio S; Sverzellati N; Uslenghi E; Caminati A; Pedrazzi G; Zompatori M
Diagn Interv Radiol; 2021 May; 27(3):329-335. PubMed ID: 34003121
[TBL] [Abstract][Full Text] [Related]
5. Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolution.
Attili AK; Kazerooni EA; Gross BH; Flaherty KR; Martinez FJ
J Thorac Imaging; 2006 Nov; 21(4):288-92. PubMed ID: 17110853
[TBL] [Abstract][Full Text] [Related]
6. Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.
Adegunsoye A; Oldham JM; Bonham C; Hrusch C; Nolan P; Klejch W; Bellam S; Mehta U; Thakrar K; Pugashetti JV; Husain AN; Montner SM; Straus CM; Vij R; Sperling AI; Noth I; Strek ME; Chung JH
Am J Respir Crit Care Med; 2019 Mar; 199(6):747-759. PubMed ID: 30216085
[TBL] [Abstract][Full Text] [Related]
7. CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy.
Niimi H; Kang EY; Kwong JS; Carignan S; Müller NL
J Comput Assist Tomogr; 1996; 20(2):305-8. PubMed ID: 8606243
[TBL] [Abstract][Full Text] [Related]
8. Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
Karampitsakos T; Galaris A; Chrysikos S; Papaioannou O; Vamvakaris I; Barbayianni I; Kanellopoulou P; Grammenoudi S; Anagnostopoulos N; Stratakos G; Katsaras M; Sampsonas F; Dimakou K; Manali ED; Papiris S; Tourki B; Juan-Guardela BM; Bakakos P; Bouros D; Herazo-Maya JD; Aidinis V; Tzouvelekis A
Respir Res; 2023 Nov; 24(1):279. PubMed ID: 37964265
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Mediastinal Lymph Node Size in Pneumococcal Pneumonia with Bacteremia.
Chopra A; Modi A; Chaudhry H; Yucel R; Rane N; Fantauzzi J; Hellwitz FJ; Judson MA
Lung; 2018 Feb; 196(1):43-48. PubMed ID: 29147774
[TBL] [Abstract][Full Text] [Related]
10. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal lymph node enlargement predicts progressive pulmonary fibrosis.
Zhai LY; Gong HH; Yu WC
Int J Tuberc Lung Dis; 2023 May; 27(5):395-400. PubMed ID: 37143232
[No Abstract] [Full Text] [Related]
12. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Aono Y; Nakamura Y; Kono M; Nakamura H; Yokomura K; Imokawa S; Toyoshima M; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620953783. PubMed ID: 32928050
[TBL] [Abstract][Full Text] [Related]
13. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
14. Mediastinal lymph node enlargement on CT scans in patients with usual interstitial pneumonitis.
Bergin C; Castellino RA
AJR Am J Roentgenol; 1990 Feb; 154(2):251-4. PubMed ID: 2105008
[TBL] [Abstract][Full Text] [Related]
15. [
Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients.
Souza CA; Müller NL; Lee KS; Johkoh T; Mitsuhiro H; Chong S
AJR Am J Roentgenol; 2006 Apr; 186(4):995-9. PubMed ID: 16554569
[TBL] [Abstract][Full Text] [Related]
17. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
[TBL] [Abstract][Full Text] [Related]
18. Serial decline in lung volume parameters on computed tomography (CT) predicts outcome in idiopathic pulmonary fibrosis (IPF).
Robbie H; Wells AU; Fang C; Jacob J; Walsh SLF; Nair A; Camoras R; Desai SR; Devaraj A
Eur Radiol; 2022 Apr; 32(4):2650-2660. PubMed ID: 34716781
[TBL] [Abstract][Full Text] [Related]
19. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Hambly N; Farooqi MM; Dvorkin-Gheva A; Donohoe K; Garlick K; Scallan C; Chong SG; MacIsaac S; Assayag D; Johannson KA; Fell CD; Marcoux V; Manganas H; Morisset J; Comes A; Fisher JH; Shapera S; Gershon AS; To T; Wong AW; Sadatsafavi M; Wilcox PG; Halayko AJ; Khalil N; Cox G; Richeldi L; Ryerson CJ; Kolb M
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35273032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
